Gene: RTL8C
Official Full Name: retrotransposon Gag like 8Cprovided by HGNC
Gene Summary: Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33726 | RTL8C Knockout cell line (HeLa) | Human | RTL8C | 1:3~1:6 | Negative | Online Inquiry |
KO33727 | RTL8C Knockout cell line (HCT 116) | Human | RTL8C | 1:2~1:4 | Negative | Online Inquiry |
KO33728 | RTL8C Knockout cell line (HEK293) | Human | RTL8C | 1:3~1:6 | Negative | Online Inquiry |
KO33729 | RTL8C Knockout cell line (A549) | Human | RTL8C | 1:3~1:4 | Negative | Online Inquiry |
RTL8C Gene Knockout Cell Lines are a groundbreaking tool in genetic research, specifically engineered to facilitate the study of gene function and disease mechanisms. These cell lines are derived from well-characterized human cell types where the RTL8C gene has been inactivated through advanced gene-editing technologies such as CRISPR/Cas9. By knocking out the RTL8C gene, researchers can observe the resultant phenotypic changes, providing valuable insights into the gene's role in cellular processes and related pathological conditions.
The primary mechanism by which these cell lines operate relies on the absence of functional RTL8C protein, allowing scientists to investigate downstream effects on cell signaling, metabolic processes, and developmental pathways. This analysis can be pivotal in identifying novel therapeutic targets for diseases where RTL8C is implicated, including certain cancers and metabolic disorders.
The scientific importance of RTL8C Gene Knockout Cell Lines lies in their versatility and applicability in both research and clinical settings. They provide a reliable model for drug screening, gene therapy, and genetic studies, making them essential for laboratories focused on translational medicine. Unlike traditional models, these knockout lines offer a more precise representation of gene function, paving the way for breakthroughs in understanding genetic contributions to disease.
Compared to alternative cell lines, RTL8C knockout models present unique advantages such as reduced background variability and enhanced reproducibility, which are critical for generating reliable data. This specificity allows researchers to delve deeper into RTL8C-related pathways without interference from other genes, streamlining experiments and improving overall research outcomes.
For researchers and clinicians alike, RTL8C Gene Knockout Cell Lines represent a valuable resource that can drive innovation in genetic studies and therapies. Their precise characterizations and robust functionalities empower study designs that aim to translate findings from bench to bedside.
Our company specializes in providing advanced biological research tools backed by years of expertise in genetic technology and cell line development. We are committed to delivering high-quality products that cater to the evolving needs of the scientific community, supporting studies that eventually bring tangible improvements in patient care.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.